Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Aspire Biopharma Holdings ( (ASBP) ) has shared an update.
On April 15, 2026, Aspire Biopharma Holdings, Inc. announced it had signed a non-binding letter of intent to acquire 100% of the Driver Controls Systems business unit of Firefish Topco, LLC, including its equity, assets, and liabilities with certain exclusions. The enterprise value is set at $30 million on a cash-free, debt-free basis, payable in cash at closing with customary tax and debt adjustments but no working capital adjustment, and the company does not expect to raise new equity to fund the deal.
The LOI includes mutual break-up fees of $3.5 million under specified failure-to-close or bad faith circumstances, subject to customary exceptions. It also grants the sellers a 30-day no-shop exclusivity period with limited carve-outs and imposes confidentiality obligations, while emphasizing that the transaction remains non-binding and contingent on negotiating a definitive purchase agreement and, separately, a management services agreement with Lakewood & Company for post-closing operations of DCS.
More about Aspire Biopharma Holdings
Aspire Biopharma Holdings, Inc. is a Delaware-based company that is expanding its activities into the automotive sector through the potential acquisition of Driver Controls Systems, a business unit of Firefish Topco, LLC. The planned engagement of Lakewood & Company, whose principals have extensive automotive industry experience, signals a strategic move to build operational capabilities in vehicle driver control technologies.
Average Trading Volume: 766,249
Technical Sentiment Signal: Sell
Current Market Cap: $5.73M
For an in-depth examination of ASBP stock, go to TipRanks’ Overview page.